P2-M fake drugs seized; 7 doctors probedBaguio City, Aug 2014 — The Philippine Drug Enforcement Agency (PDEA) has cracked down on a syndicate distributing counterfeit medicines in the city through seven doctors believed to be prescribing the bogus drugs to their patients.
Turkish man pleads guilty to importing illegal cancer drugsTurkey, August, 2014 - Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges of smuggling misbranded and adulterated cancer treatment drugs into the United States.
US FDA approves B Braun's Nutrilipid 20% Bethlehem, Pennsylvania, August 2014: The US Food and Drug Administration (US FDA) has granted approval to B. Braun Medical's Nutrilipid 20 per cent (I.V. fat emulsion) for parenteral nutrition therapy in adult & paediatric patients. Nutrilipid 20 per cent is indicated as a source of calories and essential fatty acids for parenteral nutrition and as a source of essential fatty acids when a deficiency occurs when oral or enteral nutrition is not possible, insufficient, or contraindicated.
Merck's insomnia drug, Belsomra receives US FDA approval Whitehouse Station, New Jersey, August 2014: The US Food and Drug Administration (FDA) has approved Merck's Belsomra (suvorexant) for adults with insomnia who have difficulty falling asleep and/or staying asleep.
Baxter begins recall of two lots of peritoneal dialysis solution from US market due to presence of particulate matter
Deerfield, Illinois, August 2014: Baxter International, a global, diversified healthcare company, announced that the company has voluntarily initiating a recall in the United States of two lots of Dianeal Low Calcium (2.5mEq/L) peritoneal dialysis Solution with 2.5 per cent Dextrose 5000mL (Ambu-Flex II) to the hospital/user level. The recall is being initiated due to the presence of oxidised stainless steel, garment fibre, and PVC particulate matter identified during the manufacturing process.
US FDA approves Biogen's Plegridy for multiple sclerosis treatment
Cambridge, August 2014: The US Food and Drug Administration (FDA) has approved Biogen Idec's Plegridy (peginterferon beta-1a), a new treatment for people with relapsing forms of multiple sclerosis (RMS). Plegridy, the only pegylated beta interferon approved for use in RMS, is dosed once every two weeks and can be administered subcutaneously with the Plegridy PEN, a new, ready-to-use autoinjector, or a prefilled syringe. Plegridy offers people with MS robust efficacy, a safety profile consistent with the established interferon class, and significantly fewer injections than other beta interferon treatments,” said George A. Scangos, chief executive officer of Biogen Idec. “Plegridy represents the most significant innovation in the interferon class in over a decade, and is the result of our deep commitment to improving the lives of people with MS and those who care for them.”
US FDA grants orphan drug designation to Mirati Therapeutics' mocetinostat for diffuse large B-cell lymphoma
SanDiego, August 2014: The US Food and Drug Administration (FDA) has granted Orphan Drug Designation to Mirati Therapeutics' mocetinostat, a spectrum selective HDAC inhibitor, for diffuse large B-cell lymphoma (DLBCL). In June, mocetinostat was granted Orphan Drug Designation as a treatment for myelodysplastic syndrome (MDS). Orphan drug designation is also being sought for bladder cancer patients with specific genetic alterations.
Frequently Asked Questions Q1. What are multivitamin preparations?
Answer: A multivitamin is a preparation intended to be a dietary supplement with vitamins, dietary minerals, and other nutritional elements. Such preparations are available in the form of tablets, capsules, pastilles, powders, liquids, and injectable formulations. Multivitamins are popular amongst majority of people ( from child to aged population) as they believe that these vitamins, minerals and herbs will cure colds, strengthen immunity, build muscles, improve memory, digestive disorders and generally benefit their health and lifespan.
Q2. Are multivitamins safe for regular intake?
Answer: Multivitamins are a good way to help supplement a diet for those who don't always have time to shop for fresh vegetables, fruit and whole grains. But most health experts agree that a multivitamin is no replacement for a good, well-balanced diet. Also, studies have found that an overdose of vitamins A, D, E, or K and minerals can cause serious or life-threatening side effects, serious hypersensitivity, allergies and critical medical conditions. So, a tender advice from PSM India Desk that next time before popping up a one-a-day vitamin supplement please discuss it with your doctor and tell him about all your medical conditions and allergies. In some cases, you may not be able to use multivitamins, or you may need a dose adjustment or special precautions (especially in pregnancy, lactation, etc).